Goldman Sachs trades at 2.40 times book value, pricing in peak 18.4% return on equity. With investment banking backlog falling and capital ratios tightening to 12.4%, earnings face cyclical deceleration toward $64.42 in 2027. We initiate with a Sell rating and an $805.00 target.
Key points
- $893.00 share price values the bank at 2.40 times book value, requiring a perpetual 18.4% return on equity that exceeds its 14% to 16% target.
- 12.4% CET1 capital ratio leaves a narrow 100 basis point buffer over regulatory floors, restricting buyback acceleration into 2027.
- $805.00 price target reflects cyclical normalization to a 16.5% return on equity and 12.5 times 2027 earnings of $64.42 per share.
The call
The stock trades at 2.40 times book value and 12.8 times peak earnings. This valuation requires return on common equity to stay perpetually above 18%, far exceeding the firm's historical cycle average. With investment banking backlogs contracting sequentially and credit provisions increasing, the market is pricing peak cyclical earnings as durable baseline performance.
Quarterly Net Revenues and Net Earnings ($B)Quarterly net revenues and net earnings ($B). Source: Form 8-K filings and analyst estimates.
We forecast 2027 net earnings of $18.81 billion, or $64.42 per share, as trading and financing normalize from exceptional highs. Attributing a 12.5 times multiple, consistent with global investment banks facing regulatory capital headwinds and slower asset expansion, yields an $805.00 price target. The shares offer unfavorable asymmetry following their multi-quarter re-rating.
12-Month Target Scenarios vs Spot Price ($)- Base Case ($64.42 EPS / 16.5% ROE)
- Through-Cycle ($58.56 EPS / 15.0% ROE)
12-month price targets across 2027 ROE and forward P/E scenarios. Source: Firm models.
Valuation
| Valuation step | Driver / Multiple | Value per share |
|---|
| Projected 2027 common equity | $114.15 billion | , |
| Normalized 2027 ROE | 16.5% | , |
| Projected 2027 net income to common | $18.81 billion | , |
| Diluted share count | 292.0 million | , |
| Projected 2027 diluted EPS | $64.42 per share | , |
| Target price-to-earnings multiple | 12.5 times | $805.25 |
| Twelve-month price target | Rounded | $805.00 |
Our 12.5 times multiple sits below diversified universal peer JPMorgan at 14.2 times and wealth-centric peer Morgan Stanley at 15.3 times. Goldman Sachs remains primarily exposed to market-sensitive trading and banking revenues, leaving it vulnerable to volume deceleration. A return toward historical capital returns produces negative asymmetry, supporting a Sell rating.
Risks
- A prolonged surge in cross-border merger activity and equity underwriting that rapidly replenishes contracted advisory backlogs.
- Acceleration in recurring alternatives management fees if third-party fundraising significantly surpasses the $150 billion annual projection.
- Favorable regulatory adjustments to the Basel III Endgame rules that substantially release standardized capital requirements.
What would change my mind
We would reconsider our view if investment banking backlog rebounds to new record highs alongside sustained ROE above 19% without expanding regulatory risk-weighted assets.
